Hjem › Neuroblastom › Massachusetts › Boston
Kliniske studier for Neuroblastom i Boston, MA
13 studier for Neuroblastom søker deltakere på steder i og rundt Boston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekruttererFase 3
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
MCT for the Harvard/UCSF ROBIN Center
Rekrutterer
- Brigham and Women's Hospital, Boston
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RekruttererFase 1/2
- Dana-Farber Cancer Institute ( Site 1013), Boston
B7-H3.CD28Z.CART in Solid Tumors
RekruttererFase 1
- Dana Farber Cancer Institite, Boston
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekruttererFase 3
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruttererFase 1/2
- Dana-Farber Cancer Institute, Boston
SPEARHEAD-3 Pediatric Study
RekruttererFase 1/2
- Dana Farber Cancer Institute, Boston
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
RekruttererFase 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
RekruttererFase 2
- Boston Children's Hospital, Dana-Farber Cancer Institute., Boston
Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
RekruttererFase 1
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Neuroblastoma Biology Study
RekruttererObservasjonsstudie
- Children's Hospital Boston, Boston
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Rekrutterer
- Dana-Farber Cancer Institute, Boston
Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
RekruttererFase 1/2
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Neuroblastom-studier i andre byer
- Washington, DC11 studier
- New York City, NY10 studier
- Dallas, TX9 studier
- Memphis, TN9 studier
- Philadelphia, PA9 studier
- St. Louis, MO9 studier
- Aurora, CO8 studier
- Hartford, CT8 studier
- Minneapolis, MN8 studier
- Birmingham, AL8 studier
- Atlanta, GA7 studier
- San Francisco, CA7 studier
Andre studier i Boston
- Brystkreft111 studier
- Ikke-småcellet lungekreft90 studier
- Kreft (alle typer)86 studier
- Kolorektal kreft63 studier
- Metastatisk kreft63 studier
- Lungekreft62 studier
- Eggstokkreft61 studier
- Prostatakreft59 studier
- Depresjon52 studier
- Endometriekreft50 studier
- Hjertesvikt44 studier
- Akut myelogen leukemi44 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.